Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein SA pseudogene 39 (RPSAP39) is a pseudogene that shares sequence homology with the protein-coding RPSA gene, which encodes ribosomal protein SA—a protein involved in ribosome structure and function, as well as cell-surface laminin receptor activity[1][5][10]. Pseudogenes such as RPSAP39 arise from gene duplication or retrotransposition events and are generally not transcribed or translated into functional proteins. There is no evidence that RPSAP39 has a direct biological function, disease association, or relevance as a drug target. The canonical protein (ribosomal protein SA, RPSA) itself is multifunctional, acting as part of the 40S ribosomal subunit and as a laminin receptor, but RPSAP39 does not appear to encode active protein and is not considered a valid therapeutic target[1][5][10]. If you are seeking actionable information for drug discovery, biomarker identification, or therapeutic targeting, RPSAP39 should not be considered, and the focus should instead be on the parent gene RPSA or its protein product[1][5][10].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein SA pseudogene 39 (RPSAP39).